Join
Live feed
·
INSIDERFilingvia Quantisnow
Travere Therapeutics Inc. logo

EVP, CHIEF COMMERCIAL OFFICER Heerma Peter exercised 258,189 shares at a strike of $15.69 and sold $17,857,830 worth of shares (283,189 units at $63.06) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 117,066 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TVTX (Travere Therapeutics Inc.) and more on Quantisnow.